Indication

Non-tuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium Complex (MAC) in adults with limited treatment options who do not have cystic fibrosis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Medicine details

Medicine name:
amikacin (Arikayce)
SMC ID:
SMC2369
Pharmaceutical company
Insmed
BNF chapter
Respiratory system
Submission type
Full
Publication due date:
13 September 2021
SMC meeting date:
03 August 2021
Patient group submission deadline:
31 May 2021